🇺🇸 FDA
Patent

US 10584355

Chimpanzee adenoviral vector-based filovirus vaccines

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10584355 (Chimpanzee adenoviral vector-based filovirus vaccines) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/545, A61K39/12